国科恒泰：11月27日召开董事会会议

Group 1 - The company Guoke Hengtai (SZ 301370) announced on November 28 that its third board meeting was held on November 27, 2025, to review the proposal for amending the "Rules of Procedure for Board Meetings" [1] - For the first half of 2025, Guoke Hengtai's revenue composition was as follows: vascular interventional treatment materials accounted for 71.09%, other products 14.58%, non-vascular interventional treatment materials 5.27%, orthopedic implant materials 5.12%, and oral products 2.25% [1] - As of the report date, Guoke Hengtai's market capitalization was 5.4 billion yuan [1]